



Study with the several resources on Docsity
Earn points by helping other students or get them with a premium plan
Prepare for your exams
Study with the several resources on Docsity
Earn points to download
Earn points by helping other students or get them with a premium plan
Community
Ask the community for help and clear up your study doubts
Discover the best universities in your country according to Docsity users
Free resources
Download our free guides on studying techniques, anxiety management strategies, and thesis advice from Docsity tutors
Answers and explanations to various pharmacology-related questions that may appear on an advanced pharmacology midterm exam. Topics covered include ace inhibitor contraindications, alternative treatments for statin intolerant patients, beta blocker contraindications, drug interactions and dosing considerations, and more.
Typology: Exams
1 / 6
This page cannot be seen from the preview
Don't miss anything!
ACE inhibitors contraindications - ANSWER: African American, 2nd/3rd timester pregnancy, renal disease ACEI and ARBs can lead to renal failure in who? - ANSWER: Patients w/ bilateral renal artery stenosis Alternative treatment strategies for statin intolerant patients - ANSWER: ezetimibe, fibrates, nicotinic acid, bile acid sequestrates combo therapy with infrequent statin dosing dietary changes switching to a different statin appropriate intervals for medication adjustments - ANSWER: 4 - 6 weeks is ideal before adding another drug to the therapy regimen Beer's Criteria - ANSWER: Criteria for "Potentially Inappropriate Medication Use in Older Adults"; identifies drugs with a high likelihood of causing adverse effects in older adults pg. 62 in textbook for table Beta Blockers Contraindications - ANSWER: severe HF, Bradycardia, Advanced Heart block, Hypotension (persistent), cardiogenic shock BP meds approved for pregnancy - ANSWER: Labetalol and Methyldopa Carbamazepine drug interactions & dosing considerations - ANSWER: narrow therapeutic dose (toxicity is a risk) CCB Mech of action - ANSWER: Promotes relaxation of peripheral arterioles resulting in a decreased afterload which reduces cardiac oxygen demand classes of controlled substances: - ANSWER: Anabolic steroids, narcotics, stimulants, depressants, and hallucinogens clinical tools for treating hyperlipidemia - ANSWER: ASCVD risk category, AHA/ACC, clinical guidelines
CYP450 inducers and inhibitors - ANSWER: inducers: carbamazepine phenobarbital phenytoin rifampin griseofulvin inhibitors: cimetidine ciprofloxacin erythromycin all azole antifungals grapefruit juice isoniazid ritonavir protease inhibitors DEA (Federal Drug Enforcement Administration) - ANSWER: regulate drugs and other substances based on their potential for abuse and dependence digoxin dosaging adjustments and cautions - ANSWER: start low, risk of toxicity, requires frequent monitoring of serum levels; do not use w/ quinidine drug of choice for lowering LDL - ANSWER: Statins drug schedules - schedule 2 - ANSWER: combination drugs w/ < 15mg hydrocodone per dosage unit High potential for abuse and severe physical/psychological dependence examples: Vicodin, cocaine, methamphetamine, methadone, Dilaudid, oxycodone, Meperidine, Fentanyl, Adderall, Ritalin drug schedules - schedule 3 - ANSWER: drugs w/ <90 mg of codeine per dosage unit abuse would lead to mod-low physical dependence and high psychological dependence examples: ketamine, tylenol w/ codeine, anabolic steroids, testosterone drug schedules - schedule 4 - ANSWER: low potential for abuse; low level of dependence
Excretion of Drugs: Decreased renal blood flow Decreased glomerular filtration rate Decreased tubular secretion Decreased number of nephrons Prescriptive considerations for older adults - ANSWER: decreased renal function--> serum drug accumulation polypharmacy increased illness other comorbidities (CHF, cirrhosis, CKD, DM etc.) lower therapeutic index altered pharmacokinetics (drug movement thru body) inadequate long term therapy supervision poor compliance Ranolazine contraindications - ANSWER: patients who have preexisting QT prolongation & patients w/ hepatic impairment responsibilities of prescribing - ANSWER: *safe and competent prescribing must have a documented patient-provider relationship no personal prescribing! documented thorough H+P discussion of side effects, risks/benefits, alternative options documented plan for monitoring/titration etc. if applicable consider cost, availability, CPGs, compatibility, indication Role of aldosterone and how to manage those effects? - ANSWER: can cause cardiac inflammation, hypertophy, fibrosis, arrythmias, and ischemia. Spironolactone is an aldosterone blocker that prevents these effects Statin Lifespan considerations - ANSWER: OK in children >10 years old do not use in pregnancy/breastfeeding
65 yrs old greatly reduces risk of MI statin side effects - ANSWER: Myalgia (muscle pain)